Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Munich - Delayed Quote EUR

PT Kalbe Farma Tbk (LCLA.MU)

Compare
0.0540
+0.0060
+(12.50%)
At close: April 11 at 8:00:47 AM GMT+2
Loading Chart for LCLA.MU
  • Previous Close 0.0480
  • Open 0.0540
  • Bid 0.0555 x --
  • Ask 0.0780 x --
  • Day's Range 0.0540 - 0.0540
  • 52 Week Range 0.0440 - 0.0940
  • Volume 0
  • Avg. Volume 3,128
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Apr 29, 2025 - May 5, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: LCLA.MU

View More

Performance Overview: LCLA.MU

Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is IDX COMPOSITE (^JKSE) .

YTD Return

LCLA.MU
15.63%
IDX COMPOSITE (^JKSE)
11.55%

1-Year Return

LCLA.MU
100.17%
IDX COMPOSITE (^JKSE)
14.06%

3-Year Return

LCLA.MU
100.00%
IDX COMPOSITE (^JKSE)
13.07%

5-Year Return

LCLA.MU
100.00%
IDX COMPOSITE (^JKSE)
34.70%

Compare To: LCLA.MU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LCLA.MU

View More

Valuation Measures

Annual
As of 4/10/2025
  • Market Cap

    2.85B

  • Enterprise Value

    2.62B

  • Trailing P/E

    12.63

  • Forward P/E

    11.85

  • PEG Ratio (5yr expected)

    1.09

  • Price/Sales (ttm)

    1.25

  • Price/Book (mrq)

    1.79

  • Enterprise Value/Revenue

    1.48

  • Enterprise Value/EBITDA

    10.47

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: LCLA.MU

View More

Company Insights: LCLA.MU

Research Reports: LCLA.MU

View More